“Convenience-Size” OTCs Inner Package Labeling Limits Supported
This article was originally published in The Tan Sheet
Executive Summary
FDA limits on the information that must appear on the inner package of one- and two-dose size OTC drugs are supported by drug relabeler Mechanical Servants in May 13 comments to the agency
You may also be interested in...
OTC “Convenience-Size” Two-Dose Rule Should Allow For Exemptions – CHPA
FDA should extend its classification of "convenience-size" OTCs beyond the two-dose limit outlined in a recent rule partially delaying "Drug Facts" labeling compliance for such products, the Consumer Healthcare Products Association says
OTC “Convenience-Size” Two-Dose Rule Should Allow For Exemptions – CHPA
FDA should extend its classification of "convenience-size" OTCs beyond the two-dose limit outlined in a recent rule partially delaying "Drug Facts" labeling compliance for such products, the Consumer Healthcare Products Association says
OTC “Convenience-Size” Two-Dose Rule Should Allow For Exemptions – CHPA
FDA should extend its classification of "convenience-size" OTCs beyond the two-dose limit outlined in a recent rule partially delaying "Drug Facts" labeling compliance for such products, the Consumer Healthcare Products Association says